Andrea Agathoklis Murino

Andrea Agathoklis Murino

Partner Co-Chair, Antitrust + Competition
Andrea Agathoklis Murino

Andrea Agathoklis Murino is a partner and co-chair of Goodwin’s Antitrust + Competition Law Practice. Companies rely on Ms. Murino’s vast experience with antitrust and competition law counseling and seek her expertise when pursuing clearance for proposed transactions from the Antitrust Division of the U.S. Department of Justice (DOJ), the U.S. Federal Trade Commission (FTC), state attorneys general, and international competition law enforcement agencies. Each client can expect a tailored strategy, driven by Ms. Murino’s understanding of the underlying substantive antitrust risk, as well as her experience with the antitrust authorities, to create a quick and efficient path to clearance. In the past year alone, she has successfully represented more than 75 clients through FTC and DOJ public and non-public investigations under the Hart-Scott-Rodino Act (HSR), as well as successfully avoided enforcement actions in connection with several FTC and DOJ investigations into non-HSR reportable transactions. Ms. Murino also has extensive merger litigation experience, including serving as a senior  member of a trial team that sought to defend a rare consummated merger challenge in federal court. She further advises clients on civil non-merger conduct matters before the DOJ, FTC, and state attorneys general, as well as in private litigation, and on a range of consumer protection matters. Her clients include companies in the healthcare, medical devices, pharmaceuticals, high-technology, computer hardware and software, financial services, telecommunications, energy, hospitality, retail, and consumer products industries, as well as trade associations.

Ms. Murino served the highest decision-makers at both federal antitrust enforcement agencies. She was an attorney advisor to former FTC Chairman and Commissioner William Kovacic where she offered advice on a diverse array of competition and consumer protection matters.  She then served as a counsel to two Assistant Attorneys General for Antitrust at the Department of Justice where she advised the Assistant Attorney General and the Deputy Assistant Attorneys General on criminal and civil enforcement matters. She joins Goodwin after having been a partner with Wilson Sonsini Goodrich & Rosati.

Ms. Murino was recently named to Who's Who Legal Competition: Future Leaders 2017 and Global Competition Review’s 2016 Women in Antitrust list which recognizes remarkable women at the helm of law firms' competition practices around the world. In addition, she was named to the 2016 Global Competition Review 40 Under 40 list, an award recognizing the top young antitrust lawyers, enforcers and in-house counsel around the world. For the second consecutive year, she has been appointed to Law360’s Competition Law Editorial Advisory Board, where she consults and advises on significant developments impacting antitrust and competition law. Ms. Murino is recognized as a “Top Rated Antitrust Attorney” by Super Lawyers.

Areas of Practice




Ms. Murino’s work in assuring antitrust clearance in publicly announced transactions which were required to be reported under the HSR Act include:

  • Onyx Pharmaceuticals in its $10.4 billion acquisition by Amgen
  • Wirtgen Group in its $5 billion sale to John Deere & Company
  • Parexel in its $5 billion sale to Pamploma Capital
  •, Inc. in its $1.5 billion acquisition by LinkedIn Corporation
  • Partners Group in its $1.5 billion acquisition of Knowledge Universe Education
  • Xoom Corporation in its $890 million acquisition by eBay
  • AMAG Pharmaceuticals in its $700 million acquisition of Cord Blood Registry
  • Investor AB and Patricia Industries in their $415 million acquisition of BraunAbility
  • Rainmaker Group in its $300 million sale of its multi-family housing assets to RealPage, Inc. (included successfully navigating through a DOJ investigation without any remedy following issuance of a Second Request)
  • SGL Carbon in the sale of its graphite electrodes business to Showa Denko KK for $270 million (included successfully navigating through a DOJ investigation with a remedy following issuance of a Second Request)
  • Eventbrite in its $200 million acquisition of Ticketfly
  • Concert Pharmaceuticals in the sale of a CF drug to Vertex Pharmaceuticals for $160 million (included successfully navigating through an FTC investigation without any remedy following issuance of a Second Request)

Other notable work for clients outside the HSR context includes:

  • Representing Beth Israel Deaconess Medical Center, Atrius Health, Lahey Health, and Tufts University Medical Center in successfully blocking a nonprofit health organization's acquisition of South Shore Hospital Corporation and Hallmark Health. This was the first time a state court rejected a proposed antitrust settlement between the Massachusetts Attorney General's Office and private entities.
  • Providing antitrust counsel and guidance to multiple healthcare providers and healthcare systems across the United States seeking to expand their networks in proceedings before the federal antitrust authorities, their relevant state regulatory bodies, and state attorneys general.
  • Successfully representing multiple third parties in the federal district court proceedings related to the FTC and DOJ merger challenges
  • Providing ongoing, confidential guidance to three leading international investment advisors regarding risks of antitrust enforcement and potential remedies in connection with multi-billion dollar transactions.
Professional Experience

Ms. Murino is a member of the District of Columbia Bar Association, the American Bar Association (ABA), and the American Health Lawyers Association (AHLA). She is active in the ABA’s Section of Antitrust Law, presently serving as an editor of Antitrust Magazine. She was previously chair of the Programs and Teleseminars Committee, where she helped oversee the planning of 8-9 conferences per year related to various antitrust topics. She served as vice chair of the 2014 Clayton Act at 100 Symposium, the 2013 Fall Forum, the 2013 Merger Retrospective Symposium, and the 2012 Presidential Transition Report Task Force. As a member of the AHLA, she has led webinars to educate lawyers on developments at the intersection of healthcare and antitrust law.

Ms. Murino routinely guest lectures on antitrust topics at American University's Washington College of Law, Boston University School of Law, the Columbus School of Law at Catholic University, George Washington University Law School, and the University of Michigan Law School. For eight years, she served as an adjunct professor of legal research and writing at George Washington University Law School. In addition to her professional associations, Ms. Murino has been involved in numerous community and philanthropic organizations, including serving as a Director on the Board of Trustees of StrongMinds Africa, a non-profit organization seeking to empower impoverished African women by treating depression through innovative group therapy programs. Ms. Murino also serves as immediate past president of the American University Alumni Association, her undergraduate alma mater, representing the institution’s more than 120,000 alumni.

In The News







J.D., 2001
The George Washington University Law School

(With Honors)

B.A., 1998
American University, Economics and Political Science

(magna cum laude, Phi Beta Kappa, University Honors Program)



District of Columbia
New York


U.S. District Court for the District of Columbia
U.S. Supreme Court
Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers